Related Experiment Video

Updated: Mar 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K

Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C

Yan Zhang1, Na-Qiong Wu1, Sha Li1

  • 1Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

Heart, Lung & Circulation
|September 17, 2016
PubMed

Insights

Non-high-density lipoprotein cholesterol (non-HDL-C) better predicts coronary atherosclerosis severity than low-density lipoprotein cholesterol (LDL-C). This is particularly true for patients with LDL-C levels at or above the median, indicating non-HDL-C is a superior marker for cardiovascular risk assessment.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Recent guidelines advocate for targeting both low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) in lipid-modulating therapy.
  • The comparative relationship between LDL-C, non-HDL-C, and the severity of coronary atherosclerosis remains under-evaluated.

Purpose of the Study:

  • To assess whether non-HDL-C or LDL-C is more closely associated with the severity of coronary atherosclerosis.
  • To determine the predictive value of non-HDL-C versus LDL-C for coronary artery stenosis.

Main Methods:

  • A study of 1757 subjects undergoing coronary angiography without prior lipid-lowering therapy.
  • Direct measurement of LDL-C and calculation of non-HDL-C.
  • Assessment of coronary stenosis severity using the Gensini Score (GS).

Main Results:

  • Both LDL-C and non-HDL-C levels increased significantly with higher Gensini Scores.
  • Non-HDL-C showed a stronger correlation with Gensini Score (r=0.138) than LDL-C (r=0.113) in patients with coronary atherosclerosis.
  • Multivariate analysis indicated non-HDL-C (OR=1.326) was slightly superior to LDL-C (OR=1.286) in predicting high Gensini Scores, especially in patients with LDL-C at or above the median.

Conclusions:

  • Non-HDL-C is a more effective predictor of coronary atherosclerosis severity compared to LDL-C.
  • The findings support prioritizing non-HDL-C for risk assessment, particularly in individuals with elevated LDL-C levels.
Abstract

Keywords:
Coronary atherosclerosisGensini scoreLDL-CNon-HDL-C

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K
Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.9K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
697
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
558
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
692